CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. — Syracuse, New York

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. is a clinical research site located in Syracuse, New York, United States 13210.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. has participated in 102 clinical trials.

Therapeutic areas: Prostate Cancer, Gastric Cancer, Colorectal Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.?

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. conducted?

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. has 102 clinical trials on record. Their work covers Prostate Cancer, Gastric Cancer, Colorectal Cancer.

Is CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. accredited by Crixeo Health?

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.